黑色素瘤衍生的介质可以促进前转移龛：淋巴转移的十字路口。
Melanoma-derived mediators can foster the premetastatic niche: crossroad to lymphatic metastasis.
机构信息
Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Department of Oncology, Mayo Clinic, Rochester, MN, USA; Mayo Clinic Cancer Center, Mayo Clinic, Rochester, MN, USA.
出版信息
Trends Immunol. 2023 Sep;44(9):724-743. doi: 10.1016/j.it.2023.07.002. Epub 2023 Aug 10.
Abstract
The natural history of advanced malignant melanoma demonstrates that, in most cases, widespread tumor dissemination is preceded by regional metastases involving tumor-draining lymph nodes [sentinel lymph nodes (SLNs)]. Under physiological conditions, LNs play a central role in immunosurveillance to non-self-antigens to which they are exposed via afferent lymph. The dysfunctional immunity in SLNs is mediated by tumor secretory factors that allow the survival of metastatic melanoma cells within the LN by creating a premetastatic niche (PMN). Recent studies outline the altered microenvironment of LNs shaped by melanoma mediators. Here, we discuss tumor secretory factors involved in subverting tumor immunity and remodeling LNs and highlight emerging therapeutic strategies to reinvigorate antitumoral immunity in SLNs.
摘要
晚期恶性黑色素瘤的自然病程表明，在大多数情况下，广泛的肿瘤播散之前，区域转移会累及引流肿瘤的淋巴结[前哨淋巴结 (SLN)]。在生理条件下，淋巴结在针对其通过输入淋巴管暴露的非自身抗原的免疫监视中发挥核心作用。SLN 中的功能障碍性免疫是由肿瘤分泌因子介导的，这些因子通过创建预先转移的生态位 (PMN)，允许转移黑色素瘤细胞在淋巴结内存活。最近的研究概述了由黑色素瘤介质塑造的改变的淋巴结微环境。在这里，我们讨论了参与颠覆肿瘤免疫和重塑淋巴结的肿瘤分泌因子，并强调了新兴的治疗策略，以重新激活 SLN 中的抗肿瘤免疫。
相似文献
1
Melanoma-derived mediators can foster the premetastatic niche: crossroad to lymphatic metastasis.黑色素瘤衍生的介质可以促进前转移龛：淋巴转移的十字路口。
Trends Immunol. 2023 Sep;44(9):724-743. doi: 10.1016/j.it.2023.07.002. Epub 2023 Aug 10.
2
Melanoma-Derived Extracellular Vesicles Induce CD36-Mediated Pre-Metastatic Niche.黑色素瘤衍生的细胞外囊泡诱导 CD36 介导的前转移龛。
Biomolecules. 2024 Jul 11;14(7):837. doi: 10.3390/biom14070837.
3
The interplay between tumor and nodal microenvironments for the formation of nodal premetastatic niche in head and neck cancer.头颈部癌中肿瘤与淋巴结微环境相互作用形成淋巴结前转移龛。
Am J Physiol Cell Physiol. 2023 Dec 1;325(6):C1516-C1531. doi: 10.1152/ajpcell.00337.2023. Epub 2023 Nov 6.
4
Tumor-induced lymphangiogenesis in cervical lymph nodes in oral melanoma-bearing mice.口腔黑色素瘤荷瘤小鼠颈部淋巴结肿瘤诱导的淋巴管生成。
J Exp Clin Cancer Res. 2012 Oct 2;31(1):83. doi: 10.1186/1756-9966-31-83.
5
Cutaneous lymphatic drainage in patients with grossly involved nodal basins.淋巴结广泛受累患者的皮肤淋巴引流。
Ann Surg Oncol. 1999 Jun;6(4):345-9. doi: 10.1007/s10434-999-0345-4.
6
Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma.前哨淋巴结中的微小肿瘤负荷可预测黑色素瘤患者是否存在同步非前哨淋巴结转移。
J Clin Oncol. 2008 Sep 10;26(26):4296-303. doi: 10.1200/JCO.2007.15.4179. Epub 2008 Jul 7.
7
Tumor lymphangiogenesis and melanoma metastasis.肿瘤淋巴管生成与黑色素瘤转移。
J Cell Physiol. 2008 Aug;216(2):347-54. doi: 10.1002/jcp.21494.
8
Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes.黑色素瘤来源的细胞外囊泡介导淋巴改建并损害引流淋巴结中的肿瘤免疫。
J Extracell Vesicles. 2022 Feb;11(2):e12197. doi: 10.1002/jev2.12197.
9
From tumor lymphangiogenesis to lymphvascular niche.从肿瘤淋巴管生成到淋巴血管微环境。
Cancer Sci. 2009 Jun;100(6):983-9. doi: 10.1111/j.1349-7006.2009.01142.x. Epub 2009 Feb 20.
10
Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.腹股沟转移性前哨淋巴结黑色素瘤患者盆腔淋巴结受累及预后的预测因素：一项多中心研究。
Eur J Surg Oncol. 2015 Jul;41(7):823-9. doi: 10.1016/j.ejso.2015.02.005. Epub 2015 Mar 11.
引用本文的文献
1
Confronting Melanoma Radioresistance: Mechanisms and Therapeutic Strategies.应对黑色素瘤放射抗性：机制与治疗策略
Cancers (Basel). 2025 Aug 14;17(16):2648. doi: 10.3390/cancers17162648.
2
Characterizing spatial immune architecture in metastatic melanoma using high-dimensional multiplex imaging.使用高维多重成像技术表征转移性黑色素瘤中的空间免疫结构。
Front Immunol. 2025 Apr 29;16:1560778. doi: 10.3389/fimmu.2025.1560778. eCollection 2025.
3
Unleashing the therapeutic potential of tumor-draining lymph nodes: spotlight on bladder cancer.释放肿瘤引流淋巴结的治疗潜力：聚焦膀胱癌
J Transl Med. 2025 Apr 29;23(1):489. doi: 10.1186/s12967-024-05864-7.
4
Predictive Factors for Sentinel Lymph Node Positivity in Melanoma Patients-The Role of Liquid Biopsy, MicroRNA and Gene Expression Profile Panels.黑色素瘤患者前哨淋巴结阳性的预测因素——液体活检、微小RNA和基因表达谱检测板的作用
Cancers (Basel). 2025 Apr 10;17(8):1281. doi: 10.3390/cancers17081281.
5
Melanoma-derived cytokines and extracellular vesicles are interlinked with macrophage immunosuppression.黑色素瘤衍生的细胞因子和细胞外囊泡与巨噬细胞免疫抑制相互关联。
Front Mol Biosci. 2025 Jan 22;11:1522717. doi: 10.3389/fmolb.2024.1522717. eCollection 2024.
6
Biomimetic intelligent nanoplatform with cascade amplification effect for tumor synergy therapy.具有级联放大效应的用于肿瘤协同治疗的仿生智能纳米平台。
Sci Rep. 2024 Dec 28;14(1):31067. doi: 10.1038/s41598-024-82291-0.
7
Metabolic insights into tumor lymph node metastasis in melanoma.黑色素瘤肿瘤淋巴结转移的代谢见解
Cell Oncol (Dordr). 2024 Dec;47(6):2099-2112. doi: 10.1007/s13402-024-01027-4. Epub 2024 Dec 20.
8
Patient-Derived Melanoma Immune-Tumoroids as a Platform for Precise High throughput Drug Screening.患者来源的黑色素瘤免疫肿瘤样物作为精确高通量药物筛选的平台
Adv Sci (Weinh). 2024 Dec;11(48):e2408707. doi: 10.1002/advs.202408707. Epub 2024 Oct 30.
9
Pre-metastatic niche: formation, characteristics and therapeutic implication.转移前生态位：形成、特征及治疗意义
Signal Transduct Target Ther. 2024 Sep 25;9(1):236. doi: 10.1038/s41392-024-01937-7.
10
Current advance of nanotechnology in diagnosis and treatment for malignant tumors.纳米技术在恶性肿瘤诊断与治疗中的最新进展。
Signal Transduct Target Ther. 2024 Aug 12;9(1):200. doi: 10.1038/s41392-024-01889-y.
本文引用的文献
1
Localized immune surveillance of primary melanoma in the skin deciphered through executable modeling.通过可执行建模解析皮肤原发性黑素瘤的局部免疫监测。
Sci Adv. 2023 Apr 14;9(15):eadd1992. doi: 10.1126/sciadv.add1992. Epub 2023 Apr 12.
2
The Influence of Obesity on Melanoma and Sentinel Lymph Node Diagnosis: A Retrospective Monocentric Study in 1001 Patients.肥胖对黑色素瘤及前哨淋巴结诊断的影响：一项对1001例患者的回顾性单中心研究
Cancers (Basel). 2023 Mar 16;15(6):1806. doi: 10.3390/cancers15061806.
3
Immune determinants of the pre-metastatic niche.转移前生态位的免疫决定因素。
Cancer Cell. 2023 Mar 13;41(3):546-572. doi: 10.1016/j.ccell.2023.02.018.
4
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth.不断演变的肿瘤微环境：从癌症起始到转移灶生长
Cancer Cell. 2023 Mar 13;41(3):374-403. doi: 10.1016/j.ccell.2023.02.016.
5
Extracellular vesicles and melanoma: New perspectives on tumor microenvironment and metastasis.细胞外囊泡与黑色素瘤：肿瘤微环境和转移的新视角
Front Cell Dev Biol. 2023 Jan 10;10:1061982. doi: 10.3389/fcell.2022.1061982. eCollection 2022.
6
CD8 T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor.在癌症中，CD8 T 细胞的激活包括淋巴结中的初始激活阶段，随后在肿瘤内进行效应细胞分化。
Immunity. 2023 Jan 10;56(1):107-124.e5. doi: 10.1016/j.immuni.2022.12.002. Epub 2022 Dec 28.
7
Quantitative spatial evaluation of tumor-immune interactions in the immunotherapy setting of metastatic melanoma lymph nodes.转移性黑色素瘤淋巴结免疫治疗中肿瘤免疫相互作用的定量空间评估。
Front Immunol. 2022 Dec 5;13:1024039. doi: 10.3389/fimmu.2022.1024039. eCollection 2022.
8
Adipocytes Encapsulating Telratolimod Recruit and Polarize Tumor-Associated Macrophages for Cancer Immunotherapy.脂肪细胞包裹特立莫得招募并极化肿瘤相关巨噬细胞用于癌症免疫治疗。
Adv Sci (Weinh). 2023 Feb;10(5):e2206001. doi: 10.1002/advs.202206001. Epub 2022 Dec 16.
9
Adrenomedullin Secreted by Melanoma Cells Promotes Melanoma Tumor Growth through Angiogenesis and Lymphangiogenesis.黑色素瘤细胞分泌的肾上腺髓质素通过血管生成和淋巴管生成促进黑色素瘤肿瘤生长。
Cancers (Basel). 2022 Nov 29;14(23):5909. doi: 10.3390/cancers14235909.
10
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.肿瘤浸润淋巴细胞治疗或伊匹单抗治疗晚期黑色素瘤。
N Engl J Med. 2022 Dec 8;387(23):2113-2125. doi: 10.1056/NEJMoa2210233.
Zotero 插件